JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 31 No. 8 1384-1389
© 1990 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bianco, J. A.
Right arrow Articles by Appelbaum, F. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bianco, J. A.
Right arrow Articles by Appelbaum, F. R.

Effects of Propylthiouracil on the Biodistribution of an Iodine-131-Labeled Anti-Myeloid Antibody in Normal Dogs: Dosimetry and Clinical Implications

James A. Bianco, Paul A. Brown, Larry Durack, Christopher Badger, Irwin Bernstein, Janet Eary, Jim Durham, Darrell Fisher, Brenda Sandmaier, Friedrich Schuening, Rainer Storb and Frederick R. Appelbaum

Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington
Battelle Pacific Northwest Laboratories, Richland, Washington

Correspondence: For reprints contact: James A. Bianco, MD, Fred Hutchinson Cancer Research Center, 1124 Columbia St., Seattle WA, 98104.

ABSTRACT

Despite the use of near maximal doses of chemoradiotherapy, tumor recurrence remains the most frequent cause of treatment failure following marrow transplantation for leukemia. We have previously demonstrated that it is possible to selectively deliver radiation to the marrow space. In that study an initial short half-life of the radio nuclide was observed. In this study we attempted to prolong the retention of the radioiodine in marrow through the use of propylthiouracil (PTU). When administered to normal dogs, PTU pretreatment resulted in improved marrow localization of 131I-labeled DM-5. There was no appreciable loss of activity from the marrow during the 2–4 hr postinjection time interval; a finding in contrast to the control animals where marrow activity declined a mean 45±0.5% over the same time period. Additionally, in contrast to controls, a rise in plasma trichloroacetic acid (TCA) nonprecipitable activity was not demonstrated in the PTU treated group during this 2–4 hr period. These results suggest that PTU's inhibition of deiodinases resulted in longer residence time of the radionuclide in its target tissue without adversely affecting distribution to non-target organs.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1990 by the Society of Nuclear Medicine.